Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027651 (
tumor
)
685,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Quinone reductase [
NAD
(P)H:(quinone acceptor) oxidoreductase, EC 1.6.99.2], also called DT diaphorase, is a homodimeric FAD-containing enzyme that catalyzes obligatory
NAD
(P)H-dependent two-electron reductions of quinones and protects cells against the toxic and neoplastic effects of free radicals and reactive oxygen species arising from one-electron reductions. These two-electron reductions participate in the reductive bioactivation of cancer chemotherapeutic agents such as mitomycin C in
tumor
cells. Thus, surprisingly, the same enzymatic reaction that protects normal cells activates cytotoxic drugs used in cancer chemotherapy. The 2.1-A crystal structure of rat liver quinone reductase reveals that the folding of a portion of each monomer is similar to that of flavodoxin, a bacterial FMN-containing protein. Two additional portions of the polypeptide chains are involved in dimerization and in formation of the two identical catalytic sites to which both monomers contribute. The crystallographic structures of two FAD-containing enzyme complexes (one containing NADP+, the other containing duroquinone) suggest that direct hydride transfers from
NAD
(P)H to FAD and from FADH2 to the quinone [which occupies the site vacated by
NAD
(P)H] provide a simple rationale for the obligatory two-electron reductions involving a ping-pong mechanism.
...
PMID:The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. 756 29
NAD
(P)H:quinone oxidoreductase1 (DT-diaphorase or NQO1) is a flavoprotein that promotes obligatory two-electron reduction of quinones, preventing their participation in redox cycling, oxidative stress, and
neoplasia
. NQO1 is ubiquitously expressed. However, a large amount of variation in NQO1 gene expression was noticed among various human tissues. NQO1 gene is upregulated in livers of hepatocarcinoma patients, and its expression is induced in response to a variety of compounds, including planar aromatic hydrocarbons, phenolic antioxidants/chemoprotectors,
tumor
promoters, and hydrogen peroxide. Deletion mutagenesis in the NQO1 gene promoter identified several cis-elements including antioxidant response element (ARE), xenobiotic response element, and AP2 element, which regulate the expression and induction of the NQO1 gene. Among these DNA elements, ARE is the most important cis-element required for high basal expression of the NQO1 gene in
tumor
tissues, as compared to the normal tissues of the same origin, and for its induction in response to xenobiotics and antioxidants. Nucleotide sequence analysis of the ARE indicated presence of three AP1/AP1-like elements and a GCA box. Mutational analysis indicated a requirement of two AP1/AP1-like elements arranged as inverse repeats at the interval of three base pairs for the ARE activity. The GCA box in the ARE was required for optimum basal and induced expression. ARE is a novel cis-element because a single AP1/AP1-like element did not stimulate gene expression in response to xenobiotics and antioxidants. Band shift and supershift assays identified Jun, Fos, and novel proteins in the hARE-nuclear protein complexes that mediate regulation of the NQO1 gene expression.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer. 762 Feb 21
Uncouplers CCCP (2-4 microM) or DNP (200-400 microM) when added to EL-4 thymoma or Ehrlich carcinoma ascites cells initially stimulated endogenous respiration about 2-fold but then inhibited it to a first-order rate 20-25% of controls. This inhibition was accelerated by intracellular acidification or by A23187, a Ca2+/H(+)-antiporter (i.e. when mitochondrial Ca2+ efflux was stimulated) whereas Ruthenium red, an inhibitor of uniporter-driven Ca2+ efflux, significantly slowed down the effect of uncouplers. The respiratory inhibition was associated with
NAD
(P)H oxidation and was partially reversed by exogenous substrates (glutamine or glucose). In the permeabilized cells, endogenous and glutamine-supported respiration was inhibited by EGTA, while succinate-supported respiration was Ca2+ independent. It is suggested that mitochondrial Ca2+ is necessary for NADH-dependent respiration of
tumor
cells, and uncouplers inhibit it by activation of mitochondrial Ca2+ efflux.
...
PMID:Inhibition of uncoupled respiration in tumor cells. A possible role of mitochondrial Ca2+ efflux. 768 64
The rates of quinolinic and nicotinic acids and nicotinamide utilization for
NAD
biosynthesis in organs of normal rats and those with lymphosarcoma of Pliss and Walker's carcinosarcoma were studied. All three compounds were shown to be
NAD
's precursors in the liver and kidneys of normal animals. Quinolinic acid failed to stimulate the increase in
NAD
concentration in the liver of Walker carcinosarcoma-bearing rats. An insignificant rise in
NAD
concentration was registered in the liver of rats with lymphosarcoma of Pliss following quinolinic acid treatment. The rates of nicotinic acid and nicotinamide utilization in the liver of
tumor
-bearing animals were lower than in healthy controls. Quinolinic acid utilization was the most intense in the kidney of rats with Walker's carcinosarcoma while nicotinic acid and nicotinamide were mostly utilized in the kidney of rats with lymphosarcoma of Pliss. None of the three precursors caused
NAD
concentration to rise in Walker's carcinosarcoma cells whereas nicotinamide injection was followed by an increase in
NAD
concentration in Pliss lymphosarcoma cells. To summarize, the neoplastic cells under study do not use the basic pathway of
NAD
biosynthesis and are characterized by different rates of nicotinic acid and nicotinamide utilization.
...
PMID:[Basic and salvage pathways of NAD biosynthesis in organs of normal rats, tumor-bearing rats and in tumors]. 770 97
Metoclopramide (MCA), a N-substituted benzamide, causes DNA strand breaks and inhibits DNA repair in vitro and sensitizes radiation and chemotherapeutic drugs in human squamous cell carcinomas when xenographed into nude mice or in a rat glioma model. Here we report on the evaluation of the mechanism behind the radiosensitizing effects of MCA. DNA damage was measured in vivo in a CBA-mouse
tumor
line (A12B3, sarcoma
tumor
) by using both alkaline elution and nucleoid sedimentation analysis of cell suspensions prepared from either resected
tumor
, spleen tissues or whole blood samples. The amount of DNA damage caused by radiation alone, measured 30 min after the irradiation was started, was dose dependent up to 18 Gy in all tissues. The radiation-induced DNA damage in
tumor
tissue was elevated compared to radiation alone in the presence of MCA, but the level was not higher at 18 Gy compared to 6 Gy in the presence of MCA, and it was still not fully repaired 12 h after irradiation. HPLC analysis of the
NAD
pools in
tumor
tissue after DNA damage induction showed a delay in the recovery of the
NAD
pools (presumably due to the presence of still unrepaired DNA) after exposure to MCA (2 mg/kg) + radiation (6 Gy) compared to tumors exposed to radiation (6 Gy) only, which were fully restored after 48 h. These data confirm earlier published in vitro data on MCA as an inducer of DNA damage and an effector of DNA repair. In addition, the in vivo measurement of radiation-induced DNA damage and DNA repair using the nucleoid sedimentation and alkaline elution assays together with
NAD
pool determinations may prove to be effective intermediate endpoints in the evaluation of drugs as potential radiosensitizers.
...
PMID:In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide. 776 61
The effect of the local anesthetic bupivacaine on the energy metabolism of Ehrlich ascites
tumor
cells has been investigated. Even at low concentrations, bupivacaine decreased the oxygen uptake rate, but its effect was remarkably higher on the uncoupled respiration. Experiments on specific segments of the respiratory chain have shown that bupivacaine did not inhibit electron transport from Q to oxygen. Spectroscopic evidences demonstrated a
NAD
(P)H oxidation in bupivacaine-treated cells respiring on endogenous substrates, indicating that the inhibition of oxygen depended on a reduced electron transport from site 1-entering substrates to respiratory chain. The aerobic glycolysis was stimulated by low and inhibited by high bupivacaine concentrations. The increased lactate production rate was due to an activation of mitochondrial ATPase, whereas its decrease was related to an inhibition of the hexokinase activity.
...
PMID:Effect of the local anesthetic bupivacaine on the energy metabolism of Ehrlich ascites tumor cells. 778 52
Antioxidant response elements (AREs) containing 12-O-tetradecanoylphorbol-13-acetate response element (TRE) (perfect AP1) and TRE-like (imperfect AP1) elements mediate high basal transcription of the
NAD
(P)H:quinone oxidoreductase1 (NQO1) and glutathione S-transferase Ya genes in
tumor
cells and its induction in response to xenobiotics and antioxidants. Mutations in the human NQO1 gene ARE (hARE) revealed the requirement for two TRE or TRE-like elements arranged in inverse orientation at the interval of three base pairs and a GC box for optimal expression and beta-naphthoflavone induction of the NQO1 gene. A single TRE element from the human collagenase gene failed to respond to beta-naphthoflavone. These results demonstrate that ARE (2 x TRE or TRE-like elements)-containing detoxifying enzyme genes and not genes that contain 1 x TRE are responsive to xenobiotics and antioxidants. Bandshift assays showed shifting of a complex of more or less similar mobility with hARE and TRE that could be competed by each other. Mutations in the 3'-TRE of the NQO1 gene hARE eliminated binding of nuclear proteins to the hARE and resulted in the loss of basal and induced expression, indicating that 3'-TRE is the most important element within the hARE. 5'-TRE-like element within the NQO1 gene hARE is required for xenobiotic response but may not bind to the nuclear proteins by itself. The GC box located immediately following the 3'-TRE is required for optimal expression and induction of the NQO1 gene. The comparison of AREs from several different genes indicated the requirement for specific arrangement and spacing of two TRE and TRE-like elements within the AREs.
...
PMID:ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants. 789 38
Benzamide riboside exhibits significant cytotoxicity against a variety of human
tumor
cells in culture. On the basis of metabolic studies, the primary target of this drug's action appears to be IMP dehydrogenase (IMPDH). Incubation of human myelogenous leukemia K562 cells with an IC50 concentration of benzamide riboside resulted in an expansion of IMP pools (5.9-fold), with a parallel reduction in the concentration of GMP (90%), GDP (63%), GTP (55%) and dGTP (40%). On kinetic grounds, it was deduced that benzamide riboside (whose Ki versus IMPDH is 6.4 mM, while that of its 5'-monophosphate is 3.9 mM) or its 5'-monophosphate were unlikely to be responsible for inhibition of this target enzyme, IMPDH, since only micromolar concentrations of benzamide riboside were needed to exert potent inhibition of
tumor
-cell growth. Studies on the metabolism of this C-nucleoside have revealed the presence of a new peak eluting in the nucleoside diphosphate area on HPLC. Treatment of this peak with venom phosphodiesterase degraded it and concurrently nullified its inhibitory activity versus IMPDH; alkaline phosphatase, on the other hand, totally failed to digest the anabolite. These results suggest that the metabolite in question is the phosphodiester, benzamide adenine dinucleotide (BAD). Evidence that the inhibitor was an analog of
NAD
, wherein the nicotinamide moiety has been replaced by benzamide, was provided by both NMR and mass spectrometric analysis and confirmed by enzymatic synthesis. Further insight into the nature of the active principle was obtained from kinetic studies, which established that BAD competitively inhibited
NAD
utilization by partially purified IMPDH from K562 cells with a Ki of 0.118 microM. In concert, these studies establish that benzamide riboside exhibits potent antiproliferative activity by inhibiting IMPDH through BAD.
...
PMID:Cytotoxicity and characterization of an active metabolite of benzamide riboside, a novel inhibitor of IMP dehydrogenase. 790 81
Poly(ADP-ribose) polymerase (PARP) is well known for its involvement in DNA repair, although the underlying mechanisms remain unclear. Poly(ADP-ribose) is synthesized on nuclear proteins in response to DNA damage and consequently implicated in the toxicity of various xenobiotics, including anticancer agents. The metabolism of poly(ADP-ribose) in cisplatin (DDP)-sensitive (O342) and -resistant (O-342/DDP) rat ovarian
tumor
cells was investigated to explore its possible roles in DDP resistance. The poly(ADP-ribose) synthesis assayed as [3H]-
NAD
incorporation was higher by up to two-fold in the resistant O-342/DDP cells, when compared with that of its DDP-sensitive subline O-342. Furthermore, this difference still existed even in the presence of saturating concentrations of a double-stranded octameric deoxynucleotide that stimulates the enzyme directly, indicating a higher maximal poly(ADP-ribosyl)ation capacity of the resistant cells. In addition, acute treatment of O-342 cells with DDP also stimulated the polymer synthesis by up to 1.6-fold, which was totally suppressed by inclusion of 2.5 mM 3AB in the post-exposure incubation. Western blot analysis, however, failed to reveal higher levels of the enzyme proteins in the resistant cells. A higher level of endogenous DNA single strand breaks was also detected in both intact and permeabilized cells of O-342/DDP line. Taken together, these results demonstrate that the DDP resistance phenotype in these rat ovarian
tumor
cells is accompanied by a higher cellular poly(ADP-ribosyl)ation capacity, which may be linked with DDP resistance by enhancing the repair of DDP-inflicted DNA damage.
...
PMID:Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells. 797 72
NAD
(P)H:Quinone oxidoreductase1 (NQO1) is a flavoprotein which promotes obligatory two-electron reduction of quinones, preventing their participation in redox cycling, oxidative stress and
neoplasia
. High levels of NQO1 have been observed in several kinds of tumours including that of the liver, lung, colon and breast. Transcription of the NQO1 gene is increased in response to bifunctional [e.g. beta-naphthoflavone (beta-NF), 2,3,7,8,-tetrachlordibenzo-p-dioxin (dioxin)] and monofunctional [phenolic antioxidants/chemoprotectors e.g. 2(3)tert-butyl-4-hydroxy-anisole (BHA)] inducers. High basal expression of the NQO1 gene and its induction by beta-NF and BHA are mediated by 31 bp of the antioxidant response element (ARE) containing more than one copy of the AP1/AP1-like binding sites, Jun and Fos and other(s) as yet unknown regulatory proteins. The arrangement of AP1/AP1-like elements within a short region of DNA may be important for beta-NF and BHA response. The high basal expression of the NQO1 gene in several types of tumour tissues may be due to a high expression and/or modification of regulatory proteins that result from tumour formation. Signal transduction from beta-NF and BHA for increased expression of the NQO1 gene involve metabolism of beta-NF and generation of 'redox signals'. The sequence of events after generation of 'redox signals' leading to the modification/activation of regulatory proteins that bind to ARE and increase expression of the NQO1 gene are less clear. The possibilities include involvement of protein(s) which receive signals from beta-NF and BHA and modulate the Jun and Fos proteins for increased binding to the ARE element or increased activities of the transcriptional activation domains of the regulatory proteins. The modifications in the regulatory proteins may be reduction of a cysteine residue in the DNA binding domain and/or phosphorylation of the DNA binding/transcriptional activation domains. Further studies are required to identify the intermediary components in the signal transduction pathway to completely understand the mechanism of induction of the NQO1 gene expression in response to beta-NF and BHA. Dioxin induction of the NQO1 gene expression is mediated by XRE, an element best characterized in the case of the CYP1A1 gene.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Jun and Fos regulation of NAD(P)H: quinone oxidoreductase gene expression. 800 28
<< Previous
1
2
3
4
5
6
7
8
9
10